12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Wed, 24 Apr 2024 02:49:07 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Set-Cookie: UpalLiveSession=eyJpdiI6Inc4TE96UitlR3RycGI4UmdLMjV1Snc9PSIsInZhbHVlIjoiR24zYmJRVm5VUWNrUWRERzZSODhDWHBFV0ZyNkpIbk1mNmZvS0RBSGpSSW9sNnlIRWFraVUwbW1WNnN5WUxPWHhzeEdEdU9YR2ZPRjUrUlRNM1wvaW5RPT0iLCJtYWMiOiI0MDQ1NzA2NTg4YWUzMzFjMzA0ODNlYzVhMzJlZTYxZjBiOTQzNTRmMjExOTQ2MGM4NjExNmNkMWZiNTEzMmRlIn0%3D; expires=Sat, 24-Apr-2027 02:49:07 GMT; Max-Age=94608000; path=/; HttpOnly [6] => CF-Cache-Status: DYNAMIC [7] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=rXSFMcgpQyLjNZuI05kDB%2Fqi72iU62elW8pPcPMRUEgU%2Fe%2BP5jEc4unOEJYdX5ltJhco62tWJot8fNLVT9XKL0mKPM20W7cEPrq1FSX5jm9kRRwaepPyzlQpwctCiHwDukM%3D"}],"group":"cf-nel","max_age":604800} [8] => NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [9] => Server: cloudflare [10] => CF-RAY: 8792c73cdf1e4a17-SIN [11] => alt-svc: h3=":443"; ma=86400 ) 789

由中国广东省内专家研制、针对新冠肺炎的中成药“肺炎一号”，于周四正式委托药厂量产，药厂预料下周可以陆续出货，供应予省内各医院使用。但该款新药属于医院制剂，根据规定，它只能在已申报的医院内部使用，一般市民暂时无法购买。

据当地媒体报道，该款新药由5味药材制成，配方并未公开，在周二已获得省药品监督管理局优先审批通过，由广东一方制药有限公司生产。按目前公布的资料，该药有效期为半年，仅对轻症患者有治疗功效，并无预防作用，非确诊者毋须服用。，

省药品监管局早前曾进行临床试验，供广州市第八人民医院的50名轻症患者临床服用该款新药，结果50%患者的咳嗽症状消失、52.4%的咽痛症状消失、69.6%的乏力症状消失，整体症状明显好转，具较好的临床价值。